Diabetes Injectables

Virtual Workshops 20:00 - 21:30

Date:

14th April 2021

Cost:

Free

sponsor

Diabetes: Addressing diabetes challenges created by COVID-19

The i2i Network is delighted to be extending our diabetes injectables programme supporting clinical pharmacists in managing more complex patients with type 2 diabetes and designed to equip you to competently manage injectable therapies with an emphasis on doing so virtually. This new webinar will support you in addressing the challenges in patient care created by Covid-19 for patients with diabetes.

This programme is funded by Novo Nordisk.

Novo Nordisk has not had any input into the content or involvement in the creation of these materials. All materials have been developed independently by Soar Beyond and the i2i Network Faculty. (www.i2ipharmacists.co.uk/our-faculty). Soar Beyond owns all intellectual property rights for the resources and training and retains editorial rights at all times.

Page updated – March 2021

Speakers

Philip Newland-Jones

Philip Newland-Jones is a Consultant Pharmacist in Diabetes and Endocrinology and is the Clinical Director of the Diabetes and Endocrine service at University Hospitals Southampton NHS Foundation Trust. He is a member of the UKCPA Diabetes and Endocrinology Committee, the Joint British Diabetes Societies (JBDS-IP) Committee, and the Centre of Perioperative Care (CPOC) diabetes working group. At Southampton he is the clinical lead for type 1 diabetes and as an interest in severe insulin resistance.

Read Bio
Dr Kathryn Brown

Kathryn is a GP and Clinical Director for South East Oxford Health Alliance (SEOxHA) PCN. Previously a University of Leeds Medical School graduate she went on to complete her GP training in Oxford before becoming a GP partner.

 

 

Read Bio

Agenda

Attend this webinar to hear Dr Kathryn Brown’s Clinical Director perspective about the importance and expectations of the pharmacy team in addressing the diabetes backlog and health inequalities at a population-level. Phil Newland-Jones will also share best practice on intensifying and managing these patients who may have complications or their diabetes may have worsened during this pandemic.

Learning objectives:

1. To understand the practical challenges facing primary and secondary care as a result of Covid-19

2. To understand where the clinical pharmacist most adds value and can support stratification and improved management of patients

3. To consider best practice for treatment and management intensification to avoid long term complications

4. Talk through a case study of where to start in managing your population challenge and expectations

Supported by

sponsor

This programme is funded by Novo Nordisk.

Novo Nordisk has not had any input into the content or involvement in the creation of these materials. All materials have been developed independently by Soar Beyond and the i2i Network Faculty. (www.i2ipharmacists.co.uk/our-faculty). Soar Beyond owns all intellectual property rights for the resources and training and retains editorial rights at all times.

The intended audience is pharmacists working in general practice wanting to manage injectable therapies for patients with type 2 diabetes. This is to be used as a guide only and should be used to augment local guidelines or pathways. Pharmacists are encouraged to link with a GP prescribing/diabetes lead for supervision and mentorship to support clinical competence.

This workshop has already taken place.

Health Care Professionals Attend An Event

Book onto an event as a healthcare professional
  • All communication will be received through this email.
  • This field is for validation purposes and should be left unchanged.